<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8"><meta name="robots" content="noindex">  <meta name="built-on" content="2024-01-01T12:25:14.4733516"><meta name="build-number" content="${buildNumber}">       <title>Bionomics Announced The Outcomes Of An End-of-phase 2 Meeting With The FDA For BNC210 For The Acute Treatment Of Social Anxiety Disorder Into Phase 3 ... | 20231016</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="Bionomics Announced The Outcomes Of An End-of-phase 2 Meeting With The FDA For BNC210 For The Acute Treatment Of Social Anxiety Disorder Into Phase 3 ... | 20231016"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="20231016 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="2600.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="Bionomics Announced The Outcomes Of An End-of-phase 2 Meeting With The FDA For BNC210 For The Acute Treatment Of Social Anxiety Disorder Into Phase 3 ... | 20231016"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "2600.html#webpage", "url": "2600.html", "name": "Bionomics Announced The Outcomes Of An End-of-phase 2 Meeting With The FDA For BNC210 For The Acute Treatment Of Social Anxiety Disorder Into Phase 3 ... | 20231016", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "20231016 Help" }</script><!-- End Schema.org --></head>      <body data-id="2600" data-main-title="Bionomics Announced The Outcomes Of An End-of-phase 2 Meeting With The FDA For BNC210 For The Acute Treatment Of Social Anxiety Disorder Into Phase 3 ..." data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>20231016  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="2600"   id="2600.md">Bionomics Announced The Outcomes Of An End-of-phase 2 Meeting With The FDA For BNC210 For The Acute Treatment Of Social Anxiety Disorder Into Phase 3 ...</h1>  <p id="5b29d731_15"><span class="control" id="5b29d731_16">FDA Update</span></p><p id="5b29d731_17"><span class="control" id="5b29d731_18">2023-10-16 11:10</span></p><p id="5b29d731_19"><span class="control" id="5b29d731_20">https://www.ainvest.com/news/bionomics-announced-outcomes-of-an-end-of-phase-2-meeting-with-fda-for-bnc210-for-acute-treatment-of-social-anxiety-disorder-into-phase-3-studies-2310100064fcab08e65697ad/</span></p><p id="5b29d731_21">Bionomics Announced The Outcomes Of An End-of-phase 2 Meeting With The FDA For BNC210 For The Acute Treatment Of Social Anxiety Disorder Into Phase 3 Studies</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="2601.html">UBS Upgrades TAL Education to Buy, Announces $11.6 Price Target</a>   <a class="navigation-links__next" href="260.html">普洛斯：2023上半年新经济产业新机遇涌现，投资人对高品质物流基础设施投资需求持续走强</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>